|
FOR MEDIA
U.S. Adult Immunization Program:
A Checkup An Interactive Online Scientific Symposium Presented by the National Foundation for Infectious Diseases (NFID) April 2, 2009, 2:00 pm – 3:30 pm ET A scientific forum addressed key issues surrounding adult immunization including the critical need to better protect adults from serious diseases by increasing adult vaccination rates. Issues discussed within the in-depth medical primer included:
Agenda Welcome and Introduction: Tapping Into the Power of Immunity William Schaffner, MD, President-Elect, National Foundation for Infectious Diseases; Chairman, Department of Preventive Medicine, Vanderbilt University School of Medicine Goals, Rationale, Value and Timing of the Adult Immunization Schedule Andrew Kroger, MD, MPH, Medical Epidemiologist, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention Immunity and Vaccine Development: The 10-Minute Primer Jerome O. Klein, MD, Professor of Pediatrics, Boston University School of Medicine/Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center; Lecturer, Harvard Medical School From A to Z: Vaccines from Acellular Pertussis to Zoster Prevent Serious and Potentially Deadly Illnesses Robert H. Hopkins, MD, Associate Professor, University of Arkansas for Medical Sciences; Vaccine Medical Advisory Committee, Arkansas Department of Health; Adult Immunization Advisory Board Member and Arkansas Chapter Governor, American College of Physicians Focus on Influenza and Pneumococcal Vaccines Cora L. Christian, MD, MPH, AARP Board of Directors Challenges to Increasing Adult Immunization Rates Susan J. Rehm, MD, Medical Director, National Foundation for Infectious Diseases; Vice Chair, Department of Infectious Disease and Executive Director, Physician Health, Cleveland Clinic |
| Contact Us | About NFID | Adult Immunization Report | Supporting Organizations | This Web site is supported by unrestricted educational grants to the National Foundation for Infectious Diseases from GlaxoSmithKline, Merck & Co., Inc., sanofi pasteur and Wyeth Pharmaceuticals. | ![]() |